⌘K

Login Start Free

Home/Filings/4/0001415889-21-001607

4//SEC Filing

SAXE JON S 4

Accession 0001415889-21-001607

CIK 0001411685other

View on SEC.gov Company Profile

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 7:03 PM ET

Size

7.4 KB

Accession

0001415889-21-001607

Insider Transaction Report

Form 4

Period: 2021-03-19

VistaGen Therapeutics, Inc.VTGN

Director

Transactions

Exercise/Conversion
Common Stock
2021-03-19$1.50/sh+2,500$3,750→ 5,751 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-03-19−2,500→ 0 total
Exercise: $1.50From: 2018-08-29Exp: 2021-04-26→ Common Stock (2,500 underlying)

Holdings

Common Stock
(indirect: By Trust)
50,000

Documents

1 file

4
form4-03222021_040300.xmlPrimary

Issuer

VistaGen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1

filerCIK 0001114914

Filing Metadata

Form type: 4
Filed: Mar 21, 8:00 PM ET
Accepted: Mar 22, 7:03 PM ET
Size: 7.4 KB

View on SEC.gov